At the news
? NEUTRALIMPACT 2/10 144 filed Oct 8, 2026 at 19:53 ET
Ladd Delano, an officer of HealthEquity, filed a Form 144 notice of intent to sell 1,080 shares of common stock, with an estimated aggregate market value of approximately $98,448. The shares were acquired through restricted stock vesting in 2023, 2024, and 2025. The filing states the sale is mandated by a 'sell to cover' transaction for tax withholding obligations, not a discretionary trade.
- Insider: Ladd Delano (Officer)
- Shares to be sold: 1,080 shares of common stock
- Estimated aggregate market value: ~$98,448
- Acquisition dates: Restricted stock vesting on 03/29/2023, 03/27/2024, and 04/02/2025
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access